The goal of designing and performing host resistance models is to recapitulate the response to human and animal disease. BRT uses host resistance and disease models to evaluate efficacy and assess the functional capacity of the immune system. Our host resistance models are essential for evaluating the potential immunological impact of candidate therapeutics or chemicals of interest.
We have a range of models and infectious agents available (bacterial, viral, or fungal) to investigate host resistance to infection and non-communicable diseases in the context of toxicity or efficacy.
Client-specific model development services are also available.